A support association for women affected by cancer has just announced that the end of the obligation to declare the disease when taking out an insurance contract would come after 5 years instead of 10 currently.
- The “right to be forgotten” after recovering from cancer and now granted after 10 years
- This period could be quickly reduced to 5 years
- The right to be forgotten makes it possible to take out insurance without being penalized for “aggravated health risk”
For people who have recovered from cancer, the hope of turning the page on the disease for good is becoming clearer. The famous “right to be forgotten” which allows them to no longer be penalized when taking out insurance to guarantee a loan should very quickly be granted to them after 5 years instead of the ten years required so far. According to the RoseUp association – an association supporting women affected by cancer – this measure could take place before the next presidential elections in April.
It is true that reducing this “right to be forgotten” to 5 years instead of 10 was part, as RoseUp reminds us, of the promises of Emmanuel Macron’s five-year term. Hence the idea of bringing it to a conclusion before the end of his presidential mandate. A joint committee between the Assembly and the Senate is discussing this issue.
Five years after the end of the therapeutic protocol
This 5-year period is in fact already the one that allows former patients affected by cancer the “right to be forgotten” but it only applies to those who were affected by the disease before they were 21 years old. Changing the law would therefore put everyone on an equal footing, regardless of their age at the time of illness.
Once this measure is adopted, people cured of cancer will no longer be obliged to mention the fact of having been affected by the disease when they answer the health questionnaire required by insurers when taking out a loan if this This process is done 5 years after the end of the therapeutic protocol. However, this new reduced period would only concern former patients who had been treated with chemotherapy, radiotherapy or medication, excluding those who were prescribed hormone therapy or immunotherapy in addition to these treatments.
The mention of cancer when taking out insurance can be considered by the insurer as an “aggravated health risk” and give rise to financial penalties or even a refusal of coverage by the insurance.
.
